National Cancer Institute; Notice of Meeting, 42313 [E9-20170]
Download as PDF
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
Medicine, Chicago, Illinois, at telephone
number 312–503–3659 or e-mail address
jkhirsch@northwestern.edu.
At the conclusion of the regional
meetings, the ORWH will hold a
meeting at the NIH to summarize the
deliberations from the regional
conferences. The resulting report to the
ORWH and the NIH will ensure that
women’s health research in the coming
decade continues to support a vigorous
research agenda incorporating the latest
advances in technology and cuttingedge science.
Dated: August 13, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9–20149 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: October 20–22, 2009.
Time: October 20, 2009, 2 p.m. to 6 p.m.
Agenda: Welcome, Overview of the NCI
Advanced Therapeutics Platform, Expert
Panel on NCI Therapeutics Platform.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Time: October 21, 2009, 8:30 a.m. to 5:30
p.m.
Agenda: Gaining Community Input on NCI
Therapeutics Platform, Communicating with
the Community About the NCI Therapeutics
Platform, Advocates in Research Working
Group Discussion, NCI National Outreach
Network Discussion.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Time: October 22, 2009, 8:30 a.m. to 1 p.m.
Agenda: Communicating with the
Community about the NCI Therapeutics
Platform (cont’d), Engaging the Community
Around the NCI Therapeutics Platform,
Discussion with NCI Director.
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Benjamin Carollo, MPA,
Advocacy Relations Manager, Office of
Advocacy Relations, Building 31, Room
10A30, 31 Center Drive, MSC 2580, National
Cancer Institute, NIH, DHHS, Bethesda, MD
20892–2580. 301–496–0307.
carollob@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:https://
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20170 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Environmental
Health Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
42313
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Environmental Health Sciences Council.
Date: September 15–16, 2009.
Open: September 15, 2009, 8:30 a.m. to 5
p.m.
Agenda: Discussion of program policies
and issues.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Open: September 16, 2009, 8:30 a.m. to
10:30 a.m.
Agenda: Discussion of program policies
and issues.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Closed: September 16, 2009, 10:30 a.m. to
12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Contact Person: Gwen W Collman, PHD,
Interim Director, Division of Extramural
Research & Training, National Institutes of
Health, Nat. Inst. of Environmental Health
Sciences, 615 Davis Dr., KEY615/3112,
Research Triangle Park, NC 27709, (919) 541–
4980, collman@niehs.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niehs.nih.gov/dert/c-agenda.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
E:\FR\FM\21AUN1.SGM
21AUN1
Agencies
[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Page 42313]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20170]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer
Liaison Group.
Date: October 20-22, 2009.
Time: October 20, 2009, 2 p.m. to 6 p.m.
Agenda: Welcome, Overview of the NCI Advanced Therapeutics
Platform, Expert Panel on NCI Therapeutics Platform.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892.
Time: October 21, 2009, 8:30 a.m. to 5:30 p.m.
Agenda: Gaining Community Input on NCI Therapeutics Platform,
Communicating with the Community About the NCI Therapeutics
Platform, Advocates in Research Working Group Discussion, NCI
National Outreach Network Discussion.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892.
Time: October 22, 2009, 8:30 a.m. to 1 p.m.
Agenda: Communicating with the Community about the NCI
Therapeutics Platform (cont'd), Engaging the Community Around the
NCI Therapeutics Platform, Discussion with NCI Director.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Benjamin Carollo, MPA, Advocacy Relations
Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31
Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS,
Bethesda, MD 20892-2580. 301-496-0307. carollob@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page:https://deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20170 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P